Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy.
Samantha K KorverJoanne M BowenRachel J GibsonImogen A BallKate R SecombeTaylor J WainRichard M LoganJonathan TukeKelly R MeadAlison M RichardsChristos S KarapetisDorothy M KeefeJanet K CollerPublished in: Cancer chemotherapy and pharmacology (2023)
This study is the first to link both genetic and non-genetic predictors with adverse effects following fluoropyrimidine-based chemotherapy. Collectively, we report a wealth of information that warrants further investigation to elucidate the clinical significance, especially associations with genetic predictors and adverse effects.